BANCA MEDIOLANUM SPA (BMED.MI) Stock Price, Forecast & Analysis

BIT:BMED • IT0004776628

17.46 EUR
-0.15 (-0.85%)
Last: Feb 13, 2026, 07:00 PM

BMED.MI Key Statistics, Chart & Performance

Key Statistics
Market Cap13.01B
Revenue(TTM)7.50B
Net Income(TTM)1.73B
Shares745.39M
Float215.65M
52 Week High20.68
52 Week Low11.47
Yearly Dividend0.79
Dividend Yield6.35%
EPS(TTM)2.86
PE6.1
Fwd PE12.42
Earnings (Next)04-06
IPO2015-12-30
Sector
GICS SectorFinancials
GICS IndustryFinancial Services
GICS IndustryGroupFinancial Services
BMED.MI short term performance overview.The bars show the price performance of BMED.MI in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 2 -2 -4 -6 -8 -10

BMED.MI long term performance overview.The bars show the price performance of BMED.MI in the last 1, 2 and 3 years. 1 year 2 years 3 years 20 40 60 80

The current stock price of BMED.MI is 17.46 EUR. In the past month the price decreased by -11.59%. In the past year, price increased by 27.45%.

BANCA MEDIOLANUM SPA / BMED Daily stock chart

BMED.MI Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to BMED.MI. When comparing the yearly performance of all stocks, BMED.MI turns out to be only a medium performer in the overall market: it outperformed 56.41% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating
BMED.MI Full Technical Analysis Report

BMED.MI Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to BMED.MI. BMED.MI has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
BMED.MI Full Fundamental Analysis Report

BMED.MI Financial Highlights

Over the last trailing twelve months BMED.MI reported a non-GAAP Earnings per Share(EPS) of 2.86. The EPS increased by 36.68% compared to the year before.


Industry RankSector Rank
PM (TTM) 23.06%
ROA 1.92%
ROE 38.49%
Debt/Equity 0.07
Chartmill High Growth Momentum
EPS Q2Q%16%
Sales Q2Q%272.5%
EPS 1Y (TTM)36.68%
Revenue 1Y (TTM)-22%
BMED.MI financials

BMED.MI Forecast & Estimates

17 analysts have analysed BMED.MI and the average price target is 21.14 EUR. This implies a price increase of 21.1% is expected in the next year compared to the current price of 17.46.

For the next year, analysts expect an EPS growth of -1.25% and a revenue growth 4.95% for BMED.MI


Analysts
Analysts80
Price Target21.14 (21.08%)
EPS Next Y-1.25%
Revenue Next Year4.95%
BMED.MI Analyst EstimatesBMED.MI Analyst Ratings

BMED.MI Ownership

Ownership
Inst Owners13.53%
Ins Owners40.21%
Short Float %N/A
Short RatioN/A
BMED.MI Ownership

About BMED.MI

Company Profile

BMED logo image Banca Mediolanum SpA engages in the provision of commercial banking services. The company is headquartered in Basiglio, Milano and currently employs 3,825 full-time employees. The company went IPO on 2015-12-30. The company operates thorough six segments: Italy Banking, Italy Asset Management, Italy Insurance, Italy Others, Spain and Germany. The Italy Banking segment provides a comprehensive range of customized solutions, which includes different kind of current accounts, payment instruments (credit, debit and prepaid cards), mortgages and loans, among others. The Italy Asset Management segment offers savings and investments through fund management activities. The Italy Insurance segment provides life and nonlife insurance policies and pension plans. The Italy Other segment comprises a series of financial items not directly attributable to the other lines of business and relating to events and businesses that extend across several areas. The segments Spain and Germany provide the same solutions under the Italian segments.

Company Info

BANCA MEDIOLANUM SPA

Via Ennio Doris, Palazzo Meucci

Basiglio MILANO IT

Employees: 3825

BMED Company Website

BMED Investor Relations

Phone: 390290451625

BANCA MEDIOLANUM SPA / BMED.MI FAQ

What does BANCA MEDIOLANUM SPA do?

Banca Mediolanum SpA engages in the provision of commercial banking services. The company is headquartered in Basiglio, Milano and currently employs 3,825 full-time employees. The company went IPO on 2015-12-30. The company operates thorough six segments: Italy Banking, Italy Asset Management, Italy Insurance, Italy Others, Spain and Germany. The Italy Banking segment provides a comprehensive range of customized solutions, which includes different kind of current accounts, payment instruments (credit, debit and prepaid cards), mortgages and loans, among others. The Italy Asset Management segment offers savings and investments through fund management activities. The Italy Insurance segment provides life and nonlife insurance policies and pension plans. The Italy Other segment comprises a series of financial items not directly attributable to the other lines of business and relating to events and businesses that extend across several areas. The segments Spain and Germany provide the same solutions under the Italian segments.


Can you provide the latest stock price for BANCA MEDIOLANUM SPA?

The current stock price of BMED.MI is 17.46 EUR. The price decreased by -0.85% in the last trading session.


What is the dividend status of BANCA MEDIOLANUM SPA?

BANCA MEDIOLANUM SPA (BMED.MI) has a dividend yield of 6.35%. The yearly dividend amount is currently 0.79.


What is the ChartMill technical and fundamental rating of BMED stock?

BMED.MI has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


What is the Price/Earnings (PE) ratio of BANCA MEDIOLANUM SPA (BMED.MI)?

The PE ratio for BANCA MEDIOLANUM SPA (BMED.MI) is 6.1. This is based on the reported non-GAAP earnings per share of 2.86 and the current share price of 17.46 EUR.


Is BANCA MEDIOLANUM SPA (BMED.MI) expected to grow?

The Revenue of BANCA MEDIOLANUM SPA (BMED.MI) is expected to grow by 4.95% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.


What is the market capitalization of BMED stock?

BANCA MEDIOLANUM SPA (BMED.MI) has a market capitalization of 13.01B EUR. This makes BMED.MI a Large Cap stock.